Categories Multiple Myeloma

Shorla Pharma Announces US Industry Veteran Nicholas Holsman as Chief Commercial Officer

Shorla Pharma Announces US Industry Veteran Nicholas Holsman as Chief Commercial Officer CLONMEL, Ireland–(BUSINESS WIRE)–Shorla Pharma Limited (‘Shorla’), a specialty pharmaceutical company, announces the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry executive with in-depth experience in scaling oncology & specialty pharma enterprises. Shorla specializes in developing innovative oncology drugs, with […]

Read More
Categories Multiple Myeloma

Dr. Ken Anderson highlights the bright future for multiple myeloma treatment

Dr. Ken Anderson highlights the bright future for multiple myeloma treatment Ken Anderson, MD highlights the great hope for multiple myeloma patients and their families based on the many new treatment options available and the research being done to better understand the disease and develop even more effective therapies. Learn more about the Jerome Lipper […]

Read More
Categories Multiple Myeloma

FY2021 EPS Estimates for Fate Therapeutics, Inc. (NASDAQ:FATE) Decreased by Cantor Fitzgerald

FY2021 EPS Estimates for Fate Therapeutics, Inc. (NASDAQ:FATE) Decreased by Cantor Fitzgerald Fate Therapeutics, Inc. (NASDAQ:FATE) – Stock analysts at Cantor Fitzgerald dropped their FY2021 earnings estimates for shares of Fate Therapeutics in a note issued to investors on Thursday, February 25th. Cantor Fitzgerald analyst A. Young now anticipates that the biopharmaceutical company will post […]

Read More
Categories Multiple Myeloma

Liposomal Doxorubicin Volume Analysis, Segments, Value Share and Key Trends 2021-2030

Liposomal Doxorubicin Volume Analysis, Segments, Value Share and Key Trends 2021-2030 Growth Prospects of the Global Liposomal Doxorubicin Market The comprehensive study on the Liposomal Doxorubicin market provides crucial insights to the stakeholders who are vying to solidify their presence in the current and future market landscape. The various factors that are likely to shape […]

Read More
Categories Multiple Myeloma

Q2 2021 EPS Estimates for Genmab A/S (NASDAQ:GMAB) Decreased by Truist Securiti

Q2 2021 EPS Estimates for Genmab A/S (NASDAQ:GMAB) Decreased by Truist Securiti Genmab A/S (NASDAQ:GMAB) – Stock analysts at Truist Securiti dropped their Q2 2021 earnings per share (EPS) estimates for Genmab A/S in a note issued to investors on Thursday, February 25th. Truist Securiti analyst A. Goonewardene now forecasts that the company will post […]

Read More
Categories Multiple Myeloma

Weizmann study identifies genes connected to myeloma drug resistance

Weizmann study identifies genes connected to myeloma drug resistance Researchers from the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center have found 30 genes that seem to be responsible for the resistance that multiple myeloma shows to treatment, which may help lead to more informed, personalized treatment for patients. Malignant myeloma is […]

Read More
Categories Multiple Myeloma

Multiple Myeloma: MRD Detection, Single Cell RNA Sequencing, and Cell Free DNA

Multiple Myeloma: MRD Detection, Single Cell RNA Sequencing, and Cell Free DNA Earn CME: https://www.naccme.com/program/19-lm-05 In this webcast from the ‘Multiple Myeloma: Treatment Challenges and Updates’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Raphael Fonseca discusses whether recent advances translate to treatment selection. © 2019 Imedex, an HMP Company

Read More
Categories Multiple Myeloma

Vaccine pop-up clinics accused of favoritism draw strong community reaction

Vaccine pop-up clinics accused of favoritism draw strong community reaction Zac Anderson   | Sarasota Herald-Tribune The Palmer Ranch community in Sarasota County encompasses 9,000 acres in the developed portion west of Interstate 75, and more than 14,000 housing units. It is one of the largest and best-known developments in the region, and well-established after nearly […]

Read More